These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 10368068)

  • 21. [Neurophysiologic principles and clinical value of post-convulsive serum prolactin determination in epileptic seizure].
    Bauer J; Stefan H; Schrell U; Sappke U; Uhlig B
    Fortschr Neurol Psychiatr; 1989 Nov; 57(11):457-68. PubMed ID: 2513272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunocytochemistry of neuron specific enolase (NSE) in the rat brain after single and repeated epileptic seizures.
    Yardimoğlu M; Ilbay G; Dalcik C; Dalcik H; Sahin D; Ates N
    Int J Neurosci; 2008 Jul; 118(7):981-93. PubMed ID: 18569155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma concentrations of prolactin, noradrenaline, vasopressin and oxytocin during and after a prolonged epileptic seizure.
    Meierkord H; Shorvon S; Lightman SL
    Acta Neurol Scand; 1994 Aug; 90(2):73-7. PubMed ID: 7801741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of carbamazepine and oxcarbazepine on serum neuron-specific enolase in focal seizures: A randomized controlled trial.
    Maiti R; Mishra BR; Sanyal S; Mohapatra D; Parida S; Mishra A
    Epilepsy Res; 2017 Dec; 138():5-10. PubMed ID: 29028517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum neuron-specific enolase in the major subtypes of status epilepticus.
    DeGiorgio CM; Heck CN; Rabinowicz AL; Gott PS; Smith T; Correale J
    Neurology; 1999 Mar; 52(4):746-9. PubMed ID: 10078721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of serum prolactin in diagnosing epileptic seizures: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
    Chen DK; So YT; Fisher RS;
    Neurology; 2005 Sep; 65(5):668-75. PubMed ID: 16157897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum neuron-specific enolase: a new tool for seizure risk monitoring after status epilepticus.
    Hanin A; Demeret S; Denis JA; Nguyen-Michel VH; Rohaut B; Marois C; Imbert-Bismut F; Bonnefont-Rousselot D; Levy P; Navarro V; Lambrecq V
    Eur J Neurol; 2022 Mar; 29(3):883-889. PubMed ID: 34687105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Status epilepticus increases CSF levels of neuron-specific enolase and alters the blood-brain barrier.
    Correale J; Rabinowicz AL; Heck CN; Smith TD; Loskota WJ; DeGiorgio CM
    Neurology; 1998 May; 50(5):1388-91. PubMed ID: 9595992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum neuron-specific enolase in human status epilepticus.
    DeGiorgio CM; Correale JD; Gott PS; Ginsburg DL; Bracht KA; Smith T; Boutros R; Loskota WJ; Rabinowicz AL
    Neurology; 1995 Jun; 45(6):1134-7. PubMed ID: 7783877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies of neuron-specific enolase levels in serum and cerebrospinal fluid of children with neurological diseases.
    Ko FJ; Chiang CH; Wu CC; Wu L
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1990 Mar; 6(3):137-43. PubMed ID: 2342156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Time-dependent changes in the serum levels of prolactin, nesfatin-1 and ghrelin as a marker of epileptic attacks young male patients.
    Aydin S; Dag E; Ozkan Y; Arslan O; Koc G; Bek S; Kirbas S; Kasikci T; Abasli D; Gokcil Z; Odabasi Z; Catak Z
    Peptides; 2011 Jun; 32(6):1276-80. PubMed ID: 21554911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lengthening of corrected QT during epileptic seizures.
    Brotherstone R; Blackhall B; McLellan A
    Epilepsia; 2010 Feb; 51(2):221-32. PubMed ID: 19732135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum prolactin levels and neonatal seizures.
    Morales A; Bass NE; Verhulst SJ
    Epilepsia; 1995 Apr; 36(4):349-54. PubMed ID: 7607112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum neuron-specific enolase levels do not increase after electroconvulsive therapy.
    Berrouschot J; Rolle K; Kühn HJ; Schneider D
    J Neurol Sci; 1997 Sep; 150(2):173-6. PubMed ID: 9268247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A predictive parameter in patients with brain related complications after cardiac surgery?
    Isgro F; Schmidt C; Pohl P; Saggau W
    Eur J Cardiothorac Surg; 1997 Apr; 11(4):640-4. PubMed ID: 9151030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum neuron-specific enolase predicts outcome in post-anoxic coma: a prospective cohort study.
    Meynaar IA; Oudemans-van Straaten HM; van der Wetering J; Verlooy P; Slaats EH; Bosman RJ; van der Spoel JI; Zandstra DF
    Intensive Care Med; 2003 Feb; 29(2):189-95. PubMed ID: 12594583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Symptomatology of epileptic seizures in the first three years of life.
    Hamer HM; Wyllie E; Lüders HO; Kotagal P; Acharya J
    Epilepsia; 1999 Jul; 40(7):837-44. PubMed ID: 10403206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuron specific enolase as a marker of seizure related neuronal injury.
    Shaik AJ; Reddy K; Mohammed N; Tandra SR; Rukmini Mridula Kandadai ; Baba Kss S
    Neurochem Int; 2019 Dec; 131():104509. PubMed ID: 31404559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prolactin changes after seizures classified by EEG monitoring.
    Laxer KD; Mullooly JP; Howell B
    Neurology; 1985 Jan; 35(1):31-5. PubMed ID: 3965999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Capillary prolactin measurement for diagnosis of seizures.
    Fisher RS; Chan DW; Bare M; Lesser RP
    Ann Neurol; 1991 Feb; 29(2):187-90. PubMed ID: 2012387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.